The main purpose is to describe how many children were treated during 24 months or less because of CPP and how treatment worked for them. There are no participants in this trial, the study only involves reviewing participants medical past and current records and collecting information.
This is an observational, non-interventional, retrospective study to evaluate the participants characteristics, current treatment patterns and resource usage in Chinese pediatric participants diagnosed with CPP. This study will enroll approximately 1000 participants. The data available in an existing data source the Chinese CPP Big Data Platform database will be analyzed. All the participants will be assigned to a single observational cohort: • Pediatric Participants With CPP This multi-center trial will be conducted in China. The overall duration of the study will be approximately 3 years.
Study Type
OBSERVATIONAL
Enrollment
1,477
The Second Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Hainan Women and Children's Medical Center
Haikou, Hainan, China
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Wuhan, Hubei, China
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China
Percentage of Participants With CPP Treatment
Time frame: Up to approximately 10 years
Percentage of Participants With CPP Treatment at Baseline
Time frame: At Baseline
Percentage of Participants With Luteinizing hormone (LH) Suppression
Time frame: Baseline up to approximately 10 years
Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)
Time frame: Up to approximately 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China